Progressive Pulmonary Fibrosis

Respiratory
2
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Avalyn Pharmaceuticals
2 programs
2
AP01Phase 21 trial
AP01Phase 21 trial
Active Trials
NCT06329401RecruitingEst. Jun 2027
NCT06951217RecruitingEst. Dec 2031

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
2031
Avalyn PharmaceuticalsAP01
Avalyn PharmaceuticalsAP01

Clinical Trials (2)

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Start: Apr 2025Est. completion: Dec 2031
Phase 2Recruiting

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Start: Apr 2024Est. completion: Jun 2027
Phase 2Recruiting

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials
2 companies competing in this space